SCHEMBL973065

SCHEMBL973065

Nc1ccc(-c2ccc(N(c3ccccc3)c3ccccc3)cc2)c(-c2ccc(N(c3ccccc3)c3ccccc3)cc2)c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.61
MAPT P10636 4/20 0.61
CYP3A4 P08684 3/20 0.61
TDP1 Q9NUW8 3/20 0.61
KDM4E B2RXH2 3/20 0.61
L3MBTL1 Q9Y468 2/20 0.61
CYP1A2 P05177 1/20 0.61
CYP2D6 P10635 1/20 0.61
CYP2C9 P11712 1/20 0.61
CYP2C19 P33261 1/20 0.61
NPC1 O15118 4/20 0.41
RAB9A P51151 3/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
TP53 P04637 1/20 0.41
TSHR P16473 1/20 0.41
MAPK1 P28482 1/20 0.41
MEN1 O00255 4/20 0.40
HPGD P15428 4/20 0.40
KMT2A Q03164 4/20 0.40
LMNA P02545 3/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30128689 0.98 ALDH1A1 (0.64) ALDH1A1MAPTCYP3A4TDP1KDM4E
SCHEMBL2574125 0.98 ALDH1A1 (0.59) ALDH1A1MAPTCYP3A4TDP1KDM4E
SCHEMBL28036730 0.98 ALDH1A1 (0.64) ALDH1A1MAPTCYP3A4TDP1KDM4E
SCHEMBL6396170 0.91 ALDH1A1 (0.60) ALDH1A1MAPTCYP3A4TDP1KDM4E
SCHEMBL3038725 0.91 ALDH1A1 (0.64) ALDH1A1MAPTCYP3A4TDP1KDM4E
SCHEMBL29693287 0.89 ALDH1A1 (0.62) ALDH1A1MAPTCYP3A4TDP1KDM4E
SCHEMBL15449462 0.89 ALDH1A1 (0.62) ALDH1A1MAPTCYP3A4TDP1KDM4E
SCHEMBL8666169 0.89 ALDH1A1 (0.53) ALDH1A1MAPTCYP3A4TDP1KDM4E
SCHEMBL28836453 0.88 ALDH1A1 (0.60) ALDH1A1MAPTCYP3A4TDP1KDM4E
SCHEMBL18816303 0.88 ALDH1A1 (0.47) ALDH1A1MAPTCYP3A4TDP1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1582516-B1 Nitrogenous heterocyclic derivative and organic electroluminescent element employing the same IDEMITSU KOSAN CO (JP) 2013-07-17 EP disclosed
US-7981523-B2 Aromatic amine derivative and organic electroluminescence device using the same IDEMITSU KOSAN CO., LTD. (JP) 2011-07-19 US disclosed
US-7867629-B2 Nitrogenous heterocyclic derivative and organic electroluminescent element employing the same IDEMITSU KOSAN CO., LTD. (JP) 2011-01-11 US disclosed
US-20100207513-A1 OLED WITH FLUORANTHENE-MACROCYCLIC MATERIALS GLOBAL OLED TECHNOLOGY LLC 2010-08-19 US disclosed
US-20060251925-A1 6,12-Bis((bis(alkyl or cycloalkyl-substituted phenyl))-amino-)chrysene;thin films/electrical/; OLED/organic light emitters;low driving voltage, with excellent luminance and favorable efficiency of light emission; blue light with high purity; durability; flat panel displays;television; backlighting IDEMITSU KOSAN CO., LTD. (JP) 2006-11-09 US disclosed
US-20060154105-A1 Nitrogenous heterocyclic derivative and organic elecrtroluminescent element employing the same IDEMITSU KOSAN CO., LTD. (JP) 2006-07-13 US disclosed
EP-1582516-A1 NITROGENOUS HETEROCYCLIC DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT EMPLOYING THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2005-10-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060251925-A1 6,12-Bis((bis(alkyl or cycloalkyl-substituted phenyl))-amino-)chrysene;thin films/electrical/; OLED/organic light emitters;low driving voltage, with excellent luminance and favorable efficiency of light emission; blue light with high purity; durability; flat panel displays;television; backlighting OCIAD2, OCIAD1, TRPC6 ALDH1A1 2036/4885MAPT 109/4885CYP3A4 1628/4885
US-20060154105-A1 Nitrogenous heterocyclic derivative and organic elecrtroluminescent element employing the same L1CAM, NOTCH1, NUDC ALDH1A1 325/4885MAPT 2011/4885CYP3A4 847/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.